Home › Pericardial Disorders › New York
Pericardial Disorders clinical trials in New York
4 studies for Pericardial Disorders are looking for participants at sites in New York.
Cities in New York
Transition to KPL-387 Monotherapy Dosing & Administration Study
- Investigational Site 011, New York
- Investigational Site 003, New York
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Oct 28, 2026 · NCT07288216Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387
- Investigational Site 015, New York
- Investigational Site 022, New York
RecruitingPhase 2/3
Ages 18 to 80 · All sexes · Updated Oct 28, 2026 · NCT07010159An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis
- Local Site #840020, New York
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 9, 2026 · NCT06836232CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
- NYU Langone Health, New York
- Columbia University - New York Presbyterian, New York
- Lenox Hill Hospital, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06708299From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.